1. Pink Sheet

US FDA Wants Advice About Advisory Committees: Try Having Some?

 
• By Michael McCaughan

The FDA’s drug center has all but stopped holding meetings at this point, which begs the question: why do they want advice on how to make them better?

conference room
The focus on adcomm perception does not make much sense given that CDER is having so few meetings, McCaughan argues. • Source: Shutterstock

The US Food and Drug Administration is eager to correct the “persistent misconception” that recommendations by its public advisory committees amount to final decisions or are somehow binding on the agency.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from US FDA Performance Tracker

More from Regulatory Trackers